Ocular Therapeutix Ownership | Who Owns Ocular Therapeutix?
Ocular Therapeutix Ownership Summary
Ocular Therapeutix is owned by 81.09% institutional investors, 3.44% insiders, and 15.47% retail investors. Blackrock is the largest institutional shareholder, holding 8.73% of OCUL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Ocular Therapeutix shares.
OCUL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Ocular Therapeutix | 81.09% | 3.44% | 15.47% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 11.52M | 8.73% | $78.80M |
Summer road | 13.87M | 8.31% | $118.45M |
Deep track capital, lp | 12.84M | 7.69% | $109.62B |
Vr adviser | 12.76M | 7.64% | $108.99M |
Blackrock funding, inc. /de | 11.85M | 7.09% | $101.17M |
Vanguard group | 8.48M | 5.08% | $72.45M |
Avoro capital advisors | 8.06M | 4.83% | $68.83M |
Tcg crossover management | 5.32M | 3.19% | $45.43M |
State street | 3.92M | 2.97% | $26.82M |
Opaleye management | 4.34M | 2.60% | $37.08M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Summer road | 13.87M | 98.61% | $118.45M |
Acuta capital partners | 1.11M | 9.55% | $9.49B |
Vr adviser | 12.76M | 7.48% | $108.99M |
Opaleye management | 4.34M | 6.49% | $37.08M |
Rosalind advisors | 1.13M | 4.93% | $9.64M |
Tcg crossover management | 5.32M | 4.44% | $45.43M |
Deltec asset management | 2.62M | 4.42% | $22.34M |
Deep track capital, lp | 12.84M | 4.09% | $109.62B |
Logos global management lp | 3.50M | 3.50% | $29.89M |
Octagon capital advisors lp | 2.42M | 3.41% | $20.71M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 11.52M | 0.00% | 3.46M |
State street | 3.92M | 0.00% | 1.52M |
Point72 asset management | 2.94M | 0.06% | 895.30K |
Bank of america corp /de/ | 1.04M | 0.00% | 809.12K |
Blackrock funding, inc. /de | 11.85M | 0.00% | 492.32K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Assenagon asset management | - | - | -2.83M |
Perceptive advisors | 1.08M | 0.25% | -2.25M |
Braidwell lp | - | - | -2.24M |
Great point partners | - | - | -1.73M |
Opaleye management | 4.34M | 6.49% | -682.50K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
First trust advisors lp | 212.94K | 0.00% | 212.94K | $1.82M |
Raymond james financial | 201.62K | 0.00% | 201.62K | $1.72M |
Saturn v capital management | 191.46K | 0.64% | 191.46K | $1.64M |
Balyasny asset management | 97.55K | 0.00% | 97.55K | $833.10K |
Courier capital | 56.44K | 0.03% | 56.44K | $481.98K |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Parallel advisors | -1.00 |
Nelson, van denburg & campbell wealth management group | -17.00 |
Signaturefd | -76.00 |
Bessemer group | -160.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 202 | 8.60% | 137,366,906 | 2.63% | 81 | 1.26% | 93 | -1.06% | 60 | 57.89% |
Dec 31, 2024 | 177 | 2.31% | 128,615,765 | -8.11% | 77 | 1.10% | 89 | 14.10% | 36 | -21.74% |
Sep 30, 2024 | 172 | 13.91% | 139,954,059 | 2.07% | 83 | 0.78% | 79 | -13.19% | 46 | 70.37% |
Jun 30, 2024 | 151 | -0.66% | 137,118,555 | 10.64% | 103 | 1.18% | 91 | -14.95% | 27 | 17.39% |
Mar 31, 2024 | 152 | 24.59% | 123,928,594 | 68.68% | 93 | 1.24% | 107 | 69.84% | 23 | -23.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 4.81M | 3.02% | 97.26K |
Vanguard US Total Market Shares ETF | 4.64M | 2.92% | - |
iShares Russell 2000 ETF | 4.05M | 2.54% | 1.98K |
Vanguard Institutional Extnd Mkt Idx Tr | 2.01M | 1.26% | 3.01K |
Fidelity Small Cap Index | 1.54M | 0.97% | 10.23K |
iShares Russell 2000 Growth ETF | 1.38M | 0.87% | - |
State St Russell Sm/Mid Cp® Indx SL Cl I | 910.16K | 0.57% | 3.49K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 910.16K | 0.57% | 3.49K |
Artisan International Small-Mid Investor | 806.65K | 0.51% | -79.37K |
Artisan Non-U.S. Small-Mid Growth Comp | 806.65K | 0.51% | -79.37K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 02, 2025 | Waheed Nadia | Chief Medical Officer | Sell | $111.58K |
May 23, 2025 | Nayak Sanjay | Chief Strategy Officer | Sell | $13.35K |
May 23, 2025 | Kaiser Peter | Chief Development Officer | Sell | $21.32K |
May 23, 2025 | Heier Jeffrey S. | Chief Scientific Officer | Sell | $21.71K |
May 23, 2025 | Dugel Pravin | See Remarks | Sell | $152.35K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 1 | 5 |
2025 Q1 | - | 6 |
2024 Q4 | - | 4 |
2024 Q3 | - | 2 |
2024 Q2 | - | 2 |
OCUL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools